These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12508384)

  • 1. Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission.
    Katrib A; Smith MD; Ahern MJ; Slavotinek J; Stafford L; Cuello C; Bertouch JV; McNeil HP; Youssef PP
    J Rheumatol; 2003 Jan; 30(1):10-21. PubMed ID: 12508384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study.
    Young L; Katrib A; Cuello C; Vollmer-Conna U; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    Arthritis Rheum; 2001 Feb; 44(2):343-50. PubMed ID: 11229465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis.
    Katrib A; Tak PP; Bertouch JV; Cuello C; McNeil HP; Smeets TJ; Kraan MC; Youssef PP
    Rheumatology (Oxford); 2001 Sep; 40(9):988-94. PubMed ID: 11561108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis.
    Wong P; Cuello C; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    Rheumatology (Oxford); 2000 Oct; 39(10):1067-73. PubMed ID: 11035124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.
    Yoshida W; Uzuki M; Nishida J; Shimamura T; Sawai T
    Clin Exp Rheumatol; 2009; 27(4):587-93. PubMed ID: 19772789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
    O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
    Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
    Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
    Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
    Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pulse methylprednisolone on macrophage chemotactic protein-1 and macrophage inflammatory protein-1alpha in rheumatoid synovium.
    Wong PK; Cuello C; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    J Rheumatol; 2001 Dec; 28(12):2634-6. PubMed ID: 11764208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.
    Catrina AI; Lampa J; Ernestam S; af Klint E; Bratt J; Klareskog L; Ulfgren AK
    Rheumatology (Oxford); 2002 May; 41(5):484-9. PubMed ID: 12011369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.
    Kane D; Jensen LE; Grehan S; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2004 Jul; 31(7):1274-80. PubMed ID: 15229943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet's disease and familial Mediterranean fever?
    Pay S; Erdem H; Serdar M; Dinç A; Simşek I; Turan M
    Clin Rheumatol; 2002 Nov; 21(6):511-5. PubMed ID: 12447637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
    Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
    Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.